elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38800300-8F60663B-9542-4557-B8D3-5E763218FED6
Q38800300-8F60663B-9542-4557-B8D3-5E763218FED6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38800300-8F60663B-9542-4557-B8D3-5E763218FED6
Visnagin-a new protectant against doxorubicin cardiotoxicity? Inhibition of mitochondrial malate dehydrogenase 2 (MDH2) and beyond.
P2860
Q38800300-8F60663B-9542-4557-B8D3-5E763218FED6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38800300-8F60663B-9542-4557-B8D3-5E763218FED6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
94e24c2386f26a356696ea2fbbb9361efe548ecb
P2860
Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization